154 related articles for article (PubMed ID: 24573123)
41. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
[TBL] [Abstract][Full Text] [Related]
42. Giant cell reparative granuloma concurrent with squamous cell carcinoma of the temporal bone: a case report and review of the literature.
Larbcharoensub N; Pongtippan A; Tuntiyatorn L; Cheewaruangroj W; Bhummichitra K; Sirikulchayanonta V
J Med Assoc Thai; 2007 Feb; 90(2):369-75. PubMed ID: 17375645
[TBL] [Abstract][Full Text] [Related]
43. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
[TBL] [Abstract][Full Text] [Related]
44. Inverted papilloma involving the temporal bone and its association with squamous cell carcinoma: critical analysis of the literature.
Gaio E; Marioni G; Blandamura S; Staffieri A
Expert Rev Anticancer Ther; 2005 Apr; 5(2):391-7. PubMed ID: 15877533
[TBL] [Abstract][Full Text] [Related]
45. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
[TBL] [Abstract][Full Text] [Related]
46. Staging system revision.
Hirsch BE
Arch Otolaryngol Head Neck Surg; 2002 Jan; 128(1):93-4. PubMed ID: 11784271
[No Abstract] [Full Text] [Related]
47. Selective neck dissection following adjuvant therapy for advanced head and neck cancer.
Mukhija V; Gupta S; Jacobson AS; Eloy JA; Genden EM
Head Neck; 2009 Feb; 31(2):183-8. PubMed ID: 19031407
[TBL] [Abstract][Full Text] [Related]
48. Surgical management of squamous cell carcinoma of the lip: analysis of a 10-year experience in 223 patients.
Vukadinovic M; Jezdic Z; Petrovic M; Medenica LM; Lens M
J Oral Maxillofac Surg; 2007 Apr; 65(4):675-9. PubMed ID: 17368363
[TBL] [Abstract][Full Text] [Related]
49. Management outcomes following lateral temporal bone resection for ear and temporal bone malignancies.
Moore MG; Deschler DG; McKenna MJ; Varvares MA; Lin DT
Otolaryngol Head Neck Surg; 2007 Dec; 137(6):893-8. PubMed ID: 18036417
[TBL] [Abstract][Full Text] [Related]
50. Selective vs modified radical neck dissection and postoperative radiotherapy vs observation in the treatment of squamous cell carcinoma of the oral tongue.
Schiff BA; Roberts DB; El-Naggar A; Garden AS; Myers JN
Arch Otolaryngol Head Neck Surg; 2005 Oct; 131(10):874-8. PubMed ID: 16230589
[TBL] [Abstract][Full Text] [Related]
51. Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation.
Lim YC; Lee JS; Koo BS; Kim SH; Kim YH; Choi EC
Laryngoscope; 2006 Mar; 116(3):461-5. PubMed ID: 16540910
[TBL] [Abstract][Full Text] [Related]
52. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
Haughey BH; Sinha P
Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
[TBL] [Abstract][Full Text] [Related]
53. The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck.
Palme CE; MacKay SG; Kalnins I; Morgan GJ; Veness MJ
Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):103-6. PubMed ID: 17413411
[TBL] [Abstract][Full Text] [Related]
54. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes.
Veness MJ; Porceddu S; Palme CE; Morgan GJ
Head Neck; 2007 Jul; 29(7):621-31. PubMed ID: 17230560
[TBL] [Abstract][Full Text] [Related]
55. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
[TBL] [Abstract][Full Text] [Related]
56. The role of selective neck dissection (I-III) in the treatment of node negative (N0) neck in oral cancer.
Iype EM; Sebastian P; Mathew A; Balagopal PG; Varghese BT; Thomas S
Oral Oncol; 2008 Dec; 44(12):1134-8. PubMed ID: 18486527
[TBL] [Abstract][Full Text] [Related]
57. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
[TBL] [Abstract][Full Text] [Related]
58. Elective neck dissection for carcinomas of the oral cavity: occult metastases, neck recurrences, and adjuvant treatment of pathologically positive necks.
Zbären P; Nuyens M; Caversaccio M; Stauffer E
Am J Surg; 2006 Jun; 191(6):756-60. PubMed ID: 16720144
[TBL] [Abstract][Full Text] [Related]
59. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG
J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121
[TBL] [Abstract][Full Text] [Related]
60. Cancer of the external auditory canal and middle ear in Denmark from 1992 to 2001.
Madsen AR; Gundgaard MG; Hoff CM; Maare C; Holmboe P; Knap M; Thomsen LL; Buchwald C; Hansen HS; Bretlau P; Grau C
Head Neck; 2008 Oct; 30(10):1332-8. PubMed ID: 18704969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
